Gary Barnes joins Ably Realtime - Featured Image | CEO Monthly

Gary Barnes joins Ably Realtime

Image

In a spate of new hires, Gary Barnes comes on board as Ably’s new CCO.

Ably, the realtime data delivery platform, has recently onboarded Gary Barnes, previously Global Head of Sales at Thoughtworks, the global software and digital transformation consultancy.

As CCO, Gary leads Ably’s expanding sales and marketing division, paving the way for further uptake of Ably’s realtime data infrastructure. Over his 11-year tenure at Thoughtworks Gary performed in a number of sales leadership positions, helping to grow the business beyond $500m annual revenues through consistent percentage growth in the high teens. Thoughtworks currently has 40 offices spread across 14 countries.

Gary comments: “Twenty five years bringing to market developments in the software and digital services sector led me to recognize the rapidly increasing market for realtime infrastructure-as-a-service. I look forward to helping Ably grow its footprint, making live digital experiences the norm across a number of different sectors.”

Gary has experience leading high-performing sales and marketing teams through successful digital product launches and multi-million dollar revenue growth. At Ably, Gary introduces the Ably API Streamer to the realtime infrastructure market, the industry’s first realtime API management and distribution tool.

This is a universal message bus for businesses to syndicate realtime data to other businesses with wide application across every industry imaginable as realtime becomes part of the standard online experience. Ably’s current client base covers the sports and sports betting, aerospace, civil infrastructure, gaming, engagement and healthcare sectors, to name just a few. Ably currently serves 30m+ monthly end users.

Matthew O’Riordan, Ably’s Founder and CEO, commented:
“Gary’s appointment represents a significant step in Ably’s journey as it becomes recognized as the most serious, scalable serverless realtime infrastructure provider on the market.”
He adds: “Before launch in 2016 Ably’s data stream network spent three years in the R&D stages, with engineers dedicating 50,000+ hours anticipating and solving complex problems inherent in the data-streaming process. The past three years have established a firm client base and confirmed a ready, growing market for scalable realtime solutions. Gary leads us into the exciting next phase in Ably’s history as we expand our user base.”

Ashley Friedlein, Ably’s Chairman, adds:
“As the AI, ML and IoT revolutions move from conjecture to reality, we are witnessing an exponential growth in machine-to-machine communication and data exchange. We are now seeing exciting changes in Ably’s target market as businesses reorganize themselves around the realtime data economy. Gary is leading our push to become the go-to infrastructure provider in the new digital landscape”.

17
Want to Be Recognised? Enter Our Awards Today!

Learn how to get recognised for your achievements and become a nominee in our prestigious awards programmes. Discover the criteria and steps needed to showcase your leadership excellence.

Find Out More
Get recognised banner - woman holding device

You might also like

Explore insights and updates tailored for business leaders and innovators, curated to inspire success.

February 2, 2022 How to Thrive as a Great Leader in a Connected Hybrid World

Hybrid working is now a recognised part of our day to day lives, and whilst a great number of organisations may feel they’ve ‘mastered’ the art of hybrid working during the pandemic, research carried out by Leading Edge found expensive mistakes ar...

December 18, 2017 Torbjörn Sjöström: CEO of Novus

Novus is a market research and analysis company providing relevant knowledge and an understanding of why it is the way it is. We spoke to Torbjörn Sjöström as we aim to find out about the success of the company.

December 2, 2019 A Leader in the Biotech Sphere Driving the Future of Personalised Treatments

Abreos Biosciences is a privately-owned San Diego-based biotechnology company that develops precision dosing solutions for biologic therapies. We spoke with CEO Bradley Messmer to find out more about his company and their ground-breaking work.